Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: A case report

Yu Jie Chiou, Pao Yen Lin, Yu Lee*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

3 Scopus citations

Abstract

Data on the efficacy of antipsychotics as monotherapy for obsessive-compulsive disorder (OCD) are inadequate. This report presents the case of a patient with OCD that was successfully treated with risperidone as monotherapy. Assessments revealed significant reductions in OCD symptoms after risperidone treatment (4 mg/d). This report suggests the beneficial effect of risperidone for a patient with OCD comorbid with schizoaffective disorder.

Original languageEnglish
Pages (from-to)114-116
Number of pages3
JournalClinical Neuropharmacology
Volume38
Issue number3
DOIs
StatePublished - 30 05 2015

Bibliographical note

Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc. All rights reserved.

Keywords

  • obsessive compulsive disorder
  • risperidone

Fingerprint

Dive into the research topics of 'Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: A case report'. Together they form a unique fingerprint.

Cite this